Aclaris Therapeutics Inc (NASDAQ:ACRS)

13.83
Delayed Data
As of Jul 01
 -0.13 / -0.93%
Today’s Change
9.26
Today|||52-Week Range
19.97
-4.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.001.7M10.1M
 
 
 
Cost of Goods Sold0.000.00805.0K5.0M
 
 
 
Depreciation And Amortization90.0K120.0K402.0K1.9M
 
 
 
 
 
 
Operating ExpensesGross Income-90.0K-120.0K476.0K3.2M
 
 
 
 
 
General Expenses20.3M44.4M72.3M137.4M
 
 
 
 
 
Research And Development15.0M29.7M39.8M61.7M
 
 
 
 
 
Total Operating Expenses20.4M44.6M73.5M144.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.4M-44.6M-71.8M-134.1M
 
 
 
 
 
Extraordinary Charge-289.0K-4.0M-600.0K-1.3M
 
 
 
 
 
Other Expenses0.00488.0K2.1M2.7M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.6M-48.1M-70.4M-132.7M
 
 
 
 
 
Income Taxes0.000.00-1.8M0.00
 
 
Preferred Dividend-2.6M0.000.000.00
 
 
Net Income-20.6M-48.1M-68.5M-132.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.1M21.4M28.1M32.9M
 
 
 
 
 
Shares To Calculate EPS Diluted6.1M21.4M28.1M32.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.79-$2.25-$2.44-$4.03
 
 
 
 
 
EPS Diluted-$3.79-$2.25-$2.44-$4.03